Ocugen (OCGN) Current Assets (2014 - 2026)
Ocugen (OCGN) reported Current Assets of $38.6 million for Q1 2026, down 12.31% on a YoY basis from $44.0 million in Q1 2025, and up 58.39% quarter-over-quarter from $24.3 million in Q4 2025.
Ocugen (OCGN) Current Assets (2014 - 2026) Analysis & Trends
Ocugen has reported Current Assets for 13 years, with the latest figure at $38.6 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets fell 12.31% year-over-year to $38.6 million; the trailing twelve-month figure through Mar 2026 stood at $38.6 million (down 12.31% YoY), and the FY2025 full-year result was $24.3 million, down 60.54% from the prior year.
- Current Assets for Q1 2026 stood at $38.6 million, up from $24.3 million in the prior quarter.
- The five-year high for Current Assets was $138.0 million in Q1 2022, with the low at $18.6 million in Q2 2024.
- Historically, Current Assets has averaged $61.9 million across 5 years, with a median of $44.0 million in 2025.
- Annual changes were most pronounced in 2022 — Current Assets soared 168.77% — and 2024, when it plunged 74.65%.
- Ocugen's Current Assets stood at $98.5 million in 2022, then tumbled by 56.37% to $43.0 million in 2023, then jumped by 43.54% to $61.7 million in 2024, then plunged by 60.54% to $24.3 million in 2025, then jumped by 58.39% to $38.6 million in 2026.
- The last three Current Assets figures came in at $38.6 million (Q1 2026), $24.3 million (Q4 2025), and $37.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 38.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.55 Mn |
| Dec 31, 2025 | 24.34 Mn |
| Sep 30, 2025 | 37.64 Mn |
| Jun 30, 2025 | 32.88 Mn |
| Mar 31, 2025 | 43.96 Mn |
| Dec 31, 2024 | 61.68 Mn |
| Sep 30, 2024 | 40.67 Mn |
| Jun 30, 2024 | 18.62 Mn |
| Mar 31, 2024 | 30.00 Mn |
| Dec 31, 2023 | 42.97 Mn |
| Sep 30, 2023 | 56.56 Mn |
| Jun 30, 2023 | 73.45 Mn |
| Mar 31, 2023 | 84.40 Mn |
| Dec 31, 2022 | 98.49 Mn |
| Sep 30, 2022 | 107.50 Mn |
| Jun 30, 2022 | 122.57 Mn |
| Mar 31, 2022 | 138.03 Mn |
| Dec 31, 2021 | 102.65 Mn |
| Sep 30, 2021 | 113.45 Mn |
| Jun 30, 2021 | 121.63 Mn |